| SARS-CoV-2 evolution during treatment of chronic infection SA Kemp, DA Collier, RP Datir, IATM Ferreira, S Gayed, A Jahun, ... Nature 592 (7853), 277-282, 2021 | 1217* | 2021 |
| Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity E Volz, V Hill, JT McCrone, A Price, D Jorgensen, Á O’Toole, J Southgate, ... Cell 184 (1), 64-75. e11, 2021 | 1174 | 2021 |
| Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ... The Lancet Infectious Diseases 22 (1), 35-42, 2022 | 939 | 2022 |
| Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7 B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ... Cell reports 35 (13), 2021 | 479 | 2021 |
| Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study LW Meredith, WL Hamilton, B Warne, CJ Houldcroft, M Hosmillo, ... The Lancet infectious diseases 20 (11), 1263-1271, 2020 | 463 | 2020 |
| Evolution of enhanced innate immune evasion by SARS-CoV-2 LG Thorne, M Bouhaddou, AK Reuschl, L Zuliani-Alvarez, B Polacco, ... Nature 602 (7897), 487-495, 2022 | 438* | 2022 |
| Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ... The Lancet Public Health 6 (5), e335-e345, 2021 | 366 | 2021 |
| Patterns of within-host genetic diversity in SARS-CoV-2 G Tonkin-Hill, I Martincorena, R Amato, ARJ Lawson, M Gerstung, ... elife 10, e66857, 2021 | 157 | 2021 |
| Shared and distinct phenotypes and functions of human CD161++ Vα7. 2+ T cell subsets A Kurioka, AS Jahun, RF Hannaway, LJ Walker, JR Fergusson, ... Frontiers in immunology 8, 1031, 2017 | 142 | 2017 |
| Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant P Elliott, D Haw, H Wang, O Eales, CE Walters, KEC Ainslie, C Atchison, ... Science 374 (6574), eabl9551, 2021 | 135 | 2021 |
| Combined point-of-care nucleic acid and antibody testing for SARS-CoV-2 following emergence of D614G spike variant P Mlcochova, D Collier, A Ritchie, SM Assennato, M Hosmillo, N Goel, ... Cell Reports Medicine 1 (6), 2020 | 81 | 2020 |
| The impact of viral mutations on recognition by SARS-CoV-2 specific T cells TI de Silva, G Liu, BB Lindsey, D Dong, SC Moore, NS Hsu, D Shah, ... IScience 24 (11), 2021 | 76 | 2021 |
| Superspreaders drive the largest outbreaks of hospital onset COVID-19 infections CJR Illingworth, WL Hamilton, B Warne, M Routledge, A Popay, ... elife 10, e67308, 2021 | 57 | 2021 |
| Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission D Aggarwal, B Warne, AS Jahun, WL Hamilton, T Fieldman, L Du Plessis, ... Nature communications 13 (1), 751, 2022 | 47 | 2022 |
| Leaked genomic and mitochondrial DNA contribute to the host response to noroviruses in a STING-dependent manner AS Jahun, F Sorgeloos, Y Chaudhry, SE Arthur, M Hosmillo, I Georgana, ... Cell Reports 42 (3), 2023 | 35 | 2023 |
| Genomic epidemiology of COVID-19 in care homes in the East of England WL Hamilton, G Tonkin-Hill, ER Smith, D Aggarwal, CJ Houldcroft, ... Elife 10, e64618, 2021 | 35 | 2021 |
| A2B-COVID: a tool for rapidly evaluating potential SARS-CoV-2 transmission events CJR Illingworth, WL Hamilton, C Jackson, B Warne, A Popay, L Meredith, ... Molecular biology and evolution 39 (3), msac025, 2022 | 25* | 2022 |
| Interferon responses to norovirus infections: current and future perspectives AS Jahun, IG Goodfellow Journal of General Virology 102 (10), 001660, 2021 | 15 | 2021 |
| Applying prospective genomic surveillance to support investigation of hospital-onset COVID-19 WL Hamilton, T Fieldman, A Jahun, B Warne, CJR Illingworth, C Jackson, ... The Lancet Infectious Diseases 21 (7), 916-917, 2021 | 15 | 2021 |
| Murine norovirus virulence factor 1 (VF1) protein contributes to viral fitness during persistent infection C Borg, AS Jahun, L Thorne, F Sorgeloos, D Bailey, IG Goodfellow Journal of General Virology 102 (9), 001651, 2021 | 12 | 2021 |